tetano
Editor, Senior Moderator
Prev Med. 2019 May 29. pii: S0091-7435(19)30196-3. doi: 10.1016/j.ypmed.2019.05.022. [Epub ahead of print]
[h=1]A review of the cost-effectiveness of adult influenza vaccination and other preventive services.[/h] Dabestani NM[SUP]1[/SUP], Leidner AJ[SUP]2[/SUP], Seiber EE[SUP]3[/SUP], Kim H[SUP]3[/SUP], Graitcer SB[SUP]4[/SUP], Foppa IM[SUP]3[/SUP], Bridges CB[SUP]5[/SUP].
[h=3]Author information[/h]
[h=3]Abstract[/h] The Centers for Disease Control and Prevention recommend annual influenza vaccination of persons ≥6 months old. However, in 2016-17, only 43.3% of U.S. adults reported receiving an influenza vaccination. Limited awareness about the cost-effectiveness (CE) or the economic value of influenza vaccination may contribute to low vaccination coverage. In 2017, we conducted a literature review to survey estimates of the CE of influenza vaccination of adults compared to no vaccination. We also summarized CE estimates of other common preventive interventions that are recommended for adults by the U.S. Preventive Services Task Force. Results are presented as costs in US$2015 per quality-adjusted life-year (QALY) saved. Among adults aged 18-64, the CE of influenza vaccination ranged from $8000 to $39,000 per QALY. Assessments for adults aged ≥65 yielded lower CE ratios, ranging from being cost-saving to $15,300 per QALY. Influenza vaccination was cost-saving to $85,000 per QALY for pregnant women in moderate or severe influenza seasons and $260,000 per QALY in low-incidence seasons. For other preventive interventions, CE estimates ranged from cost-saving to $170,000 per QALY saved for breast cancer screening among women aged 50-74, from cost-saving to $16,000 per QALY for colorectal cancer screening, and from $27,000 to $600,000 per QALY for hypertension screening and treatment. Influenza vaccination in adults appears to have a similar CE profile as other commonly utilized preventive services for adults. Efforts to improve adult vaccination should be considered by adult-patient providers, healthcare systems and payers given the health and economic benefits of influenza vaccination.
Copyright ? 2019. Published by Elsevier Inc.
[h=4]KEYWORDS:[/h] Adult; Influenza vaccines; Literature review; Preventive medicine
PMID: 31152830 DOI: 10.1016/j.ypmed.2019.05.022
[h=1]A review of the cost-effectiveness of adult influenza vaccination and other preventive services.[/h] Dabestani NM[SUP]1[/SUP], Leidner AJ[SUP]2[/SUP], Seiber EE[SUP]3[/SUP], Kim H[SUP]3[/SUP], Graitcer SB[SUP]4[/SUP], Foppa IM[SUP]3[/SUP], Bridges CB[SUP]5[/SUP].
[h=3]Author information[/h]
[h=3]Abstract[/h] The Centers for Disease Control and Prevention recommend annual influenza vaccination of persons ≥6 months old. However, in 2016-17, only 43.3% of U.S. adults reported receiving an influenza vaccination. Limited awareness about the cost-effectiveness (CE) or the economic value of influenza vaccination may contribute to low vaccination coverage. In 2017, we conducted a literature review to survey estimates of the CE of influenza vaccination of adults compared to no vaccination. We also summarized CE estimates of other common preventive interventions that are recommended for adults by the U.S. Preventive Services Task Force. Results are presented as costs in US$2015 per quality-adjusted life-year (QALY) saved. Among adults aged 18-64, the CE of influenza vaccination ranged from $8000 to $39,000 per QALY. Assessments for adults aged ≥65 yielded lower CE ratios, ranging from being cost-saving to $15,300 per QALY. Influenza vaccination was cost-saving to $85,000 per QALY for pregnant women in moderate or severe influenza seasons and $260,000 per QALY in low-incidence seasons. For other preventive interventions, CE estimates ranged from cost-saving to $170,000 per QALY saved for breast cancer screening among women aged 50-74, from cost-saving to $16,000 per QALY for colorectal cancer screening, and from $27,000 to $600,000 per QALY for hypertension screening and treatment. Influenza vaccination in adults appears to have a similar CE profile as other commonly utilized preventive services for adults. Efforts to improve adult vaccination should be considered by adult-patient providers, healthcare systems and payers given the health and economic benefits of influenza vaccination.
Copyright ? 2019. Published by Elsevier Inc.
[h=4]KEYWORDS:[/h] Adult; Influenza vaccines; Literature review; Preventive medicine
PMID: 31152830 DOI: 10.1016/j.ypmed.2019.05.022